Achieve Life Sciences, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for ACHV, updated each market day.
ACHV AI Sentiment
AI sees no strong directional signal for Achieve Life Sciences, Inc. stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Achieve Life Sciences, Inc.
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Sector
Exchange
Market Cap
$813,958,695
Cap Tier
Employees
28
Headquarters
SEATTLE, WA
Listed Since
Oct. 12, 1995
ACHV Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ACHV Volatility
Achieve Life Sciences, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
